skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 5,657  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Material Type:
Article 		Add to My Research

Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors

Nature medicine, 2021-11, Vol.27 (11), p.2002-2011 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01542-z ;PMID: 34594036

Full text available

Citations Cited by
2
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report
Material Type:
Article 		Add to My Research

Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report

Nature communications, 2020-12, Vol.11 (1), p.6385-11, Article 6385 [Peer Reviewed Journal]

The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-020-19761-2 ;PMID: 33318491

Full text available

Citations Cited by
3
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity
Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity
Material Type:
Article 		Add to My Research

Author Correction: A Engineered immunogen binding to alum adjuvant enhances humoral immunity

Nature medicine, 2020-05, Vol.26 (5), p.804-804 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;COPYRIGHT 2020 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2020 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-020-0861-0 ;PMID: 32405059

Full text available

Citations Cited by
4
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals
Material Type:
Article 		Add to My Research

Detection of SARS-CoV-2-Specific Humoral and Cellular Immunity in COVID-19 Convalescent Individuals

Immunity (Cambridge, Mass.), 2020-06, Vol.52 (6), p.971-977.e3 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Inc. ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2020.04.023 ;PMID: 32413330

Digital Resources/Online E-Resources

Citations Cited by
5
Evolution of antibody immunity to SARS-CoV-2
Evolution of antibody immunity to SARS-CoV-2
Material Type:
Article 		Add to My Research

Evolution of antibody immunity to SARS-CoV-2

Nature (London), 2021-03, Vol.591 (7851), p.639-644 [Peer Reviewed Journal]

COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Mar 25, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03207-w ;PMID: 33461210

Full text available

Citations Cited by
6
CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer
CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer
Material Type:
Article 		Add to My Research

CD8 + T cells contribute to survival in patients with COVID-19 and hematologic cancer

Nature medicine, 2021-07, Vol.27 (7), p.1280-1289 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01386-7 ;PMID: 34017137

Full text available

Citations Cited by
7
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia
Material Type:
Article 		Add to My Research

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

The Lancet, 2020-09, Vol.396 (10255), p.887-897 [Peer Reviewed Journal]

2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31866-3 ;PMID: 32896291

Digital Resources/Online E-Resources

Citations Cited by
8
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
Material Type:
Article 		Add to My Research

Preexisting and de novo humoral immunity to SARS-CoV-2 in humans

Science, 2020-12, Vol.370 (6522) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abe1107

Digital Resources/Online E-Resources

Citations Cited by
9
IgA Responses to Microbiota
IgA Responses to Microbiota
Material Type:
Article 		Add to My Research

IgA Responses to Microbiota

Immunity (Cambridge, Mass.), 2018-08, Vol.49 (2), p.211-224 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;Copyright Elsevier Limited Aug 21, 2018 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2018.08.011 ;PMID: 30134201

Full text available

Citations Cited by
10
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Distinct Early Serological Signatures Track with SARS-CoV-2 Survival
Material Type:
Article 		Add to My Research

Distinct Early Serological Signatures Track with SARS-CoV-2 Survival

Immunity, 2020-09, Vol.53 (3), p.524-532.e4 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. The Authors ;2020 The Authors 2020 ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2020.07.020 ;PMID: 32783920

Digital Resources/Online E-Resources

Citations Cited by
11
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy
Material Type:
Article 		Add to My Research

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

Nature medicine, 2021-11, Vol.27 (11), p.1990-2001 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01507-2 ;PMID: 34522051

Full text available

Citations Cited by
12
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
Material Type:
Article 		Add to My Research

SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19

Nature communications, 2021-03, Vol.12 (1), p.1813-1813, Article 1813 [Peer Reviewed Journal]

The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-22034-1 ;PMID: 33753738

Full text available

Citations Cited by
13
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient
Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient
Material Type:
Article 		Add to My Research

Prolonged Severe Acute Respiratory Syndrome Coronavirus 2 Replication in an Immunocompromised Patient

The Journal of infectious diseases, 2021-01, Vol.223 (1), p.23-27 [Peer Reviewed Journal]

The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. ;The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com. 2020 ;ISSN: 0022-1899 ;EISSN: 1537-6613 ;DOI: 10.1093/infdis/jiaa666 ;PMID: 33089317

Full text available

Citations Cited by
14
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity
Material Type:
Article 		Add to My Research

Impact of circulating SARS-CoV-2 variants on mRNA vaccine-induced immunity

Nature (London), 2021-12, Vol.600 (7889), p.523-529 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Dec 16, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-04085-y ;PMID: 34634791

Full text available

Citations Cited by
15
Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection
Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection
Material Type:
Article 		Add to My Research

Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection

Nature communications, 2018-11, Vol.9 (1), p.5037-14, Article 5037 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-07492-4 ;PMID: 30487586

Full text available

Citations Cited by
16
PI3Kδ: Too much of a good thing
PI3Kδ: Too much of a good thing
Material Type:
Article 		Add to My Research

PI3Kδ: Too much of a good thing

Nature immunology, 2018-09, Vol.19 (9), p.910-911 [Peer Reviewed Journal]

Copyright Nature Publishing Group Sep 2018 ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-018-0183-2 ;PMID: 30127436

Full text available

Citations Cited by
17
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion
Material Type:
Article 		Add to My Research

Unexpected Receptor Functional Mimicry Elucidates Activation of Coronavirus Fusion

Cell, 2019-02, Vol.176 (5), p.1026-1039.e15 [Peer Reviewed Journal]

2018 Elsevier Inc. ;Copyright © 2018 Elsevier Inc. All rights reserved. ;2019. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;Distributed under a Creative Commons Attribution 4.0 International License ;2018 Elsevier Inc. 2018 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2018.12.028 ;PMID: 30712865

Digital Resources/Online E-Resources

Citations Cited by
18
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis
Selenium-GPX4 axis protects follicular helper T cells from ferroptosis
Material Type:
Article 		Add to My Research

Selenium-GPX4 axis protects follicular helper T cells from ferroptosis

Nature immunology, 2021-09, Vol.22 (9), p.1127-1139 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature America, Inc. ;COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. corrected publication 2021. ;ISSN: 1529-2908 ;EISSN: 1529-2916 ;DOI: 10.1038/s41590-021-00996-0 ;PMID: 34413521

Full text available

Citations Cited by
19
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Material Type:
Article 		Add to My Research

Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity

Immunity (Cambridge, Mass.), 2020-11, Vol.53 (5), p.925-933.e4 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Inc. ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2020.10.004 ;PMID: 33129373

Digital Resources/Online E-Resources

Citations Cited by
20
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients
Material Type:
Article 		Add to My Research

Cellular immunity predominates over humoral immunity after homologous and heterologous mRNA and vector‐based COVID‐19 vaccine regimens in solid organ transplant recipients

American Journal of Transplantation, 2021-12, Vol.21 (12), p.3990-4002 [Peer Reviewed Journal]

2021 The Authors. published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons ;2021 The Authors. American Journal of Transplantation published by Wiley Periodicals LLC on behalf of The American Society of Transplantation and the American Society of Transplant Surgeons. ;2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com ;2021. This article is published under http://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 1600-6135 ;EISSN: 1600-6143 ;DOI: 10.1111/ajt.16818 ;PMID: 34453872

Digital Resources/Online E-Resources

Citations Cited by

Results 1 - 20 of 5,657  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (5,426)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1978  (10)
  2. 1978 To 1992  (15)
  3. 1993 To 2002  (24)
  4. 2003 To 2012  (1,149)
  5. After 2012  (4,459)
  6. More options open sub menu

Subject 

  1. Science & Technology  (5,104)
  2. Life Sciences & Biomedicine  (4,343)
  3. Animals  (3,130)
  4. Humans  (3,039)
  5. Immunity, Humoral  (3,021)
  6. Immunology  (2,429)
  7. Female  (2,170)
  8. Immunity  (1,843)
  9. Vaccines  (1,806)
  10. Mice  (1,765)
  11. Immune Response  (1,738)
  12. Male  (1,522)
  13. Antibodies  (1,321)
  14. Antigens  (1,250)
  15. Vaccination  (1,234)
  16. Infections  (1,119)
  17. Immune System  (983)
  18. Proteins  (958)
  19. Medicine, Research & Experimental  (953)
  20. Research & Experimental Medicine  (953)
  21. More options open sub menu

Language 

  1. English  (5,612)
  2. Japanese  (729)
  3. Russian  (34)
  4. Portuguese  (33)
  5. French  (9)
  6. Spanish  (8)
  7. Ukrainian  (7)
  8. Norwegian  (6)
  9. Polish  (5)
  10. Chinese  (5)
  11. Slovak  (2)
  12. Czech  (2)
  13. Croatian  (2)
  14. Turkish  (1)
  15. Bosnian  (1)
  16. Lithuanian  (1)
  17. Dutch  (1)
  18. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait